Vittarthaa focuses on creating and advancing innovative drugs for the treatment of diseases: Cancer, Metabolic diseases, Urea Cycle Disorder (UCD), Hepatic Encephalopathy, and Gout. Vittarthaa utilizes the Discovery and Development platform to validate several molecules for its potency, selectivity, pharmacokinetics, and patentability. At Vittarthaa, we focus on developing best-in-class drugs for various targets.

Further information will be updated shortly.